Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
April 20, 2021 at 06:40 am
Share
Teyi Pharmaceutical Group Co.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 194.378 million compared to CNY 175.466 million a year ago. Operating income was CNY 43.637 million compared to CNY 33.291 million a year ago. Net income was CNY 41.669 million compared to CNY 22.923 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.11 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
TEYI PHARMACEUTICAL GROUP CO.,LTD 
